We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
11.50 | 0.70% | 1,651.00 | 1,651.00 | 1,652.00 | 1,656.00 | 1,637.00 | 1,650.50 | 4,661,376 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.80 | 68.01B |
TIDMGSK
RNS Number : 6381V
GlaxoSmithKline PLC
29 October 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) I give details of changes in the interests of Mr S Dingemans, a Director, in the Ordinary Shares of GlaxoSmithKline plc (the "Company") arising from the grant of 238 Share options over Ordinary Shares, at an option price of GBP11.31 per share, pursuant to the GlaxoSmithKline plc ShareSave Plan 2012, on 29 October 2014.
The Company was advised of the transaction on 29 October 2014.
V A Whyte
Company Secretary
29 October 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEKLFLZBFEFBF
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions